Skip to main content
logo
Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0636
-0.0064 (-9.14%)
At close: Jul 29, 2026

RMTG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.385.14.112.411.530.44
Revenue Growth
36.96%24.17%70.44%57.49%249.46%694.97%
Gross Profit
3.632.812.821.680.880.15
Operating Income
-0.67-0.790.13-0.71-0.99-9.82
Net Income
-7.93-7.81-5.56-9.81-5.51-12.88
Earnings Per Share
-0.62-0.62-0.44-0.79-0.45-1.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.060.961.170.531.652.98
Total Debt
20.5819.5720.0517.6515.1413.37
Net Cash (Debt)
-19.52-18.61-18.88-17.12-13.5-10.39
Net Cash Growth
------
Net Cash Per Share
-1.53-1.47-1.51-1.38-1.10-0.91

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.66-0.710.85-0.42-1.11-9.88
Capital Expenditures
-0.92-0.6-0.22-0.39-0.2-
Free Cash Flow
-1.58-1.310.64-0.8-1.31-9.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.99%55.11%68.73%69.53%57.31%34.29%
Operating Margin
-10.52%-15.43%3.25%-29.30%-64.99%-2242.37%
Pretax Margin
-124.36%-153.18%-135.43%-407.21%-364.33%-2939.41%
Profit Margin
-124.36%-153.17%-135.44%-407.21%-359.87%-2942.42%
FCF Margin
-24.77%-25.67%15.47%-33.40%-85.78%-2255.99%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--0.56---
PS Ratio
0.130.130.090.040.167.42